Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Josep M. Gatell"'
Autor:
Lorna Leal, Constanza Lucero, Josep M Gatell, Teresa Gallart, Montserrat Plana, Felipe García
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 6, Pp 587-600 (2017)
Introduction: There is a growing interest in developing curative strategies for HIV infection. Therapeutic vaccines are one of the most promising approaches. We will review the current knowledge and the new challenges in this research field. Areas co
Externí odkaz:
https://doaj.org/article/7e8bdfc55fc64d30be29f37c96ff7cc7
Autor:
Jean-Michel Molina, Kathleen Squires, Paul E Sax, Pedro Cahn, Johan Lombaard, Edwin DeJesus, Ming-Tain Lai, Anthony Rodgers, Lisa Lupinacci, Sushma Kumar, Peter Sklar, George J Hanna, Carey Hwang, Elizabeth Anne Martin, Debbie P. Hagins, Olayemi O. Osiyemi, David James Prelutsky, Moti N. Ramgopal, Anthony John Scarsella, Robin Dretler, Christopher J. Bettacchi, James Sims, Patrick G. Clay, Nicholaos C. Bellos, Melanie A. Thompson, Jose Montero, Cheryl K. McDonald, Catherine Creticos, David Shamblaw, Miguel Mogyoros, Antonio E. Terrelonge, Martin Valdes, Karen T. Tashima, William J. Robbins, Franco Antonio Felizarta, Richard A. Elion, Jihad Slim, Sandra S. Win, Sujata N. Lalla-Reddy, Peter Jerome Ruane, Anthony Mills, Jerry L. Cade, Craig A. Dietz, David Scott Rubin, Cynthia Mayer, Juan Carlos Rondon, Paul P. Cook, Eric Daar, Princy N. Kumar, Susan Swindells, Jose Guillermo Castro, Ivan Melendez-Rivera, Javier O. Morales-Ramirez, Lizette Santiago, Jorge L. Santana-Bagur, Marcelo Martins, Pedro Enrique Cahn, Gustavo D. Lopardo, Norma Porteiro, Mark Theo Bloch, David Alfred Baker, Norman Roth, Richard James Moore, Robert James Finlayson, James McMahon, Armin Rieger, Alexander Zoufaly, Sylvia Hartl, Robert Zangerle, Fiona Smaill, Sharon L. Walmsley, Brian Conway, Anita Rachlis, Graham H.R. Smith, Carlos Perez, Alejandro Afani, Maria Isabel Campos, Carolina Eugenia Chahin, Marcelo Wolff Reyes, Jan Gerstoft, Nina Weis, Alex Lund Laursen, Yazdan Yazdanpanah, Laurent Cotte, Francois Raffi, Philippe Morlat, Pierre-Marie Girard, Christine Katlama, Juergen K. Rockstroh, Keikawus Arasteh, Stefan Esser, Albrecht Stoehr, Hans-Juergen Stellbrink, Matthias Stoll, Dirk Schuermann, Gerd Faetkenheuer, Johannes Bogner, Thomas Lutz, Axel Baumgarten, Hans Jaeger, Andrea Gori, Gabriel Coltan, Felicia Constandis, Simona Manuela Erscoiu, Liviu-Jany Prisacariu, Sorin Rugina, Adrian Streinu-Cercel, Vadim Valentinovich Pokrovsky, Natalia V. Zakharova, Andrey Anatolyevich Shuldyakov, Elena Pavlovna Ryamova, Valeriy Viktorovich Kulagin, Olga Aleksandrovna Tsybakova, Elena Orlova-Morozova, Firaya Nagimova, Evgeniy Voronin, Tatyana Evgenyevna Shimonova, Oleg Anatolyevich Kozyrev, Catherine Orrell, Johannes Jurgens Lombaard, Marleen de Jager, Joaquin Portilla Segorb, Josep Mallolas, Maria Jesus Perez Elias, Josep M. Gatell, Jose Ramon Arribas Lopez, Eugenia Negredo Puigmal, Daniel Podzamczer Palter, Federico Pulido Ortega, Jesus Troya Garcia, Ignacio De los Santos Gil, Juan Berenguer Berenguer, Ian G. Williams, Margaret A. Johnson, Gabriel Schembri, Amanda Clarke, Mark Gompels, Julie Meriel Fox, Steven John Taylor, David Harold Dockrell, Stephen Kegg
Publikováno v:
The Lancet HIV. 7:e16-e26
Doravirine is a novel, non-nucleoside reverse transcriptase inhibitor that has shown non-inferior efficacy to ritonavir-boosted darunavir, with a superior lipid profile, in adults with HIV who were treatment naive at week 48 in the phase 3 DRIVE-FORW
Autor:
César Garriga, Patricia García de Olalla, Josep M Miró, Inma Ocaña, Hernando Knobel, Maria Jesús Barberá, Victoria Humet, Pere Domingo, Josep M Gatell, Esteve Ribera, Mercè Gurguí, Andrés Marco, Joan A Caylà, Barcelona HIV/AIDS working group
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145701 (2015)
INTRODUCTION:Antiretroviral therapy has led to a decrease in HIV-related mortality and to the emergence of non-AIDS defining diseases as competing causes of death. This study estimates the HIV mortality rate and their risk factors with regard to diff
Externí odkaz:
https://doaj.org/article/219b0d5da10440ff96ccf0117b81042d
Autor:
Berta Torres, Alberto C Guardo, Lorna Leal, Agathe Leon, Constanza Lucero, Míriam J Alvarez‐Martinez, Miguel J Martinez, Jordi Vila, María Martínez‐Rebollar, Ana González‐Cordón, Josep M Gatell, Montserrat Plana, Felipe García
Publikováno v:
Journal of the International AIDS Society, Vol 17, Iss 1, Pp n/a-n/a (2014)
Introduction Monotherapy with protease‐inhibitors (MPI) may be an alternative to cART for HIV treatment. We assessed the impact of this strategy on immune activation, bacterial translocation and inflammation. Methods We performed a cross‐sectiona
Externí odkaz:
https://doaj.org/article/cb10ff45b7d04009a80fb6f35f6892b7
Autor:
Narcís Saubi, Ester Gea-Mallorquí, Pau Ferrer, Carmen Hurtado, Sara Sánchez-Úbeda, Yoshiki Eto, Josep M Gatell, Tomáš Hanke, Joan Joseph
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 1, Iss C (2014)
In this study, we have engineered a new mycobacterial vaccine design by using an antibiotic-free plasmid selection system. We assembled a novel Escherichia coli (E. coli)–mycobacterial shuttle plasmid p2auxo.HIVA, expressing the HIV-1 clade A immun
Externí odkaz:
https://doaj.org/article/9bea397dedde4f32a4e8269cc1b4182b
Autor:
Marta Massanella, Dan Ouchi, Silvia Marfil, Josep M Llibre, Maria C Puertas, María J Buzón, Douglas D Richman, Elisa Orna, Mario Stevenson, Josep M Gatell, Pere Domingo, Eugènia Negredo, Javier Martinez-Picado, Bonaventura Clotet, Julià Blanco
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114142 (2014)
HIV-1 infection increases plasma levels of inflammatory markers. Combination antiretroviral therapy (cART) does not restore inflammatory markers to normal levels. Since intensification of cART with raltegravir reduced CD8 T-cell activation in the Dis
Externí odkaz:
https://doaj.org/article/d0b956c2a00c434fa05f0cfd17e7118f
Autor:
Jordi Bosch, José Luis Santiago Blanco, Alexy Inciarte, Esteban Martínez, Alejandro Blanco-Arevalo, Mercè Alsina-Gibert, Andrea Vergara, Elisa de Lazzari, Josep Mayans, Ana González-Cordón, Teresa Estrach, Josep M. Gatell, Ross D Cranston, Irene Fuertes
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 73(4)
Background Lymphogranuloma venereum (LGV) is a sexually transmitted infection caused by Chlamydia trachomatis (CT) serovars L1, L2, and L3 and is endemic among men who have sex with men (MSM) in Europe. We evaluated weekly oral azithromycin 1 g for 3
Autor:
Patrick Aloy, Ainoa Ugarte, María Florencia Etcheverry, Lorna Leal, Sonsoles Sánchez-Palomino, Josep M. Gatell, Montserrat Plana, Alberto C. Guardo, Csaba Fehér, Felipe García, Irene Fernández, Núria Climent
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 83(5)
OBJECTIVES To construct a classifier that predicts the probability of viral control after analytical treatment interruptions (ATI) in HIV research trials. METHODS Participants of a dendritic cell-based therapeutic vaccine trial (DCV2) constituted the
Autor:
Juan Carlos López Bernaldo de Quirós, Csaba Fehér, Pedro Castro, Núria Climent, Josep M. Gatell, Esteban Martínez, Felipe García, Lorna Leal, Vicens Díaz-Brito, Patrick Aloy, Montserrat Plana, Alberto C. Guardo, Beatriz Mothe
Publikováno v:
Open Forum Infectious Diseases
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Background Analytical treatment interruptions (ATI) are essential in research on HIV cure. However, the heterogeneity of virological outcome measures used in different trials hinders the interpretation of the efficacy of different strategies. Methods
Autor:
Agathe León, César Cáceres, Emma Fernández, Paloma Chausa, Maite Martin, Carles Codina, Araceli Rousaud, Jordi Blanch, Josep Mallolas, Esteban Martinez, Jose L Blanco, Montserrat Laguno, Maria Larrousse, Ana Milinkovic, Laura Zamora, Neus Canal, Josep M Miró, Josep M Gatell, Enrique J Gómez, Felipe García
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e14515 (2011)
BackgroundAntiretroviral therapy has changed the natural history of human immunodeficiency virus (HIV) infection in developed countries, where it has become a chronic disease. This clinical scenario requires a new approach to simplify follow-up appoi
Externí odkaz:
https://doaj.org/article/b8f71999e68c497b8eadc59c326f99a4